Showing results (341-350 of 895) with videos related to
Sort By:
Pageof 90
Drugs in R&D|September 4, 2013
Use of nicotinamide to treat hyperphosphatemia in dialysis patientsAurélie Lenglet, Sophie Liabeuf, Pauline Guffroy, et al.Drugs in R&D|May 19, 2012
L-asparaginase-induced pancreatic injury is associated with an imbalance in plasma amino acid levelsKei Minowa, Mitsuyoshi Suzuki, Junya Fujimura, et al.Drugs in R&D|October 31, 2013
An in vitro analysis of disintegration times of different formulations of olanzapine orodispersible tablet: a preliminary reportDavid Hobbs, Jamie Karagianis, Tamas Treuer, et al.Drugs in R&D|April 21, 2019
Safety and Efficacy of 0.5% Carbomer 980 Gel for Treatment of Symptoms of Common Cold: Results of 2 Randomized TrialsLara DennieDrugs in R&D|October 12, 2018
Isavuconazole Kinetic Exploration for Clinical PracticeLéa Darnaud, Fabien Lamoureux, Cendrine Godet, et al.Drugs in R&D|September 2, 2018
Critical Review of the Use of Second-Generation Antipsychotics in Obsessive-Compulsive and Related DisordersDongmi Kim, Nicole L Ryba, Julie Kalabalik, et al.Drugs in R&D|March 25, 2018
Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid MedicationJordi Guitart, María Isabel Vargas, Vicente De Sanctis, et al.Drugs in R&D|January 12, 2020
Evaluation of Fosphenytoin Therapeutic Drug Monitoring in the Neurocritical Care UnitMandee Noval, Hyunuk Seung, Michael ArmahizerDrugs in R&D|June 21, 2021
Potential for the Repurposing of Adamantane Antivirals for COVID-19Roger F ButterworthDrugs in R&D|May 31, 2022
Evaluation of the Effect of Food on the Pharmacokinetics of SHR6390, An Oral CDK4/6 Inhibitor, in Healthy VolunteersYan-Ping Liu, Ming-Hui Hu, Ping-Ping Lin, et al.Pageof 90